Produkty 1313382-32-9

CAS 1313382-32-9 występuje w naszej ofercie pod nazwami: Estradiol Valerate Impurity 16, 6Beta-Hydroxy-17Beta-estradiol 17-Valerate. Oferty producentów: Hubei YoungXin, TRC, Biosynth. Dostępne opakowania: 10mg, 25mg, 50mg, 100mg, 200mg, 2,5mg.

Estradiol Valerate Impurity 16
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
6Beta-Hydroxy-17Beta-estradiol 17-Valerate
TRC, Biosynth
  • opakowanie: 2,5mg, 25mg, 10mg, 50mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(6R,8R,9S,13S,14S,17S)-3,6-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate (CAS 1313382-32-9) to związek chemiczny o wzorze sumarycznym C23H32O4 i masie molowej 372.5 g/mol. Nazwa systematyczna IUPAC: [(6R,8R,9S,13S,14S,17S)-3,6-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate. InChIKey: PRZIFAMBDFWLSI-XOJSAPGMSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H32O4
Masa molowa372.5 g/mol
Nazwa IUPAC[(6R,8R,9S,13S,14S,17S)-3,6-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate
InChIKeyPRZIFAMBDFWLSI-XOJSAPGMSA-N
SMILESCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H](C4=C3C=CC(=C4)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 6b-Hydroxy-17b-estradiol 17-Valerate, (17beta)-Valeryloxyestra-1,3,5(10)-triene-3,6beta-diol Valerate
Powiązane formy tego związku
[(6S,8R,9S,13S,14S,17S)-3,6-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate C23H32O4
Izomery (ten sam wzór sumaryczny)
[(5S,8R,9R,10S,13S,14S,17R)-17-acetyl-13-methyl-16-methylidene-3-oxo-2,4,5,6,7,8,9,10,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H32O4
[(8R,9S,10R,11S,13S,14S,17R)-17-acetyl-11,13-dimethyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C23H32O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H32O4
[2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H32O4
[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C23H32O4
(15-acetyl-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-14-en-5-yl) acetate C23H32O4
[(1S,2R,5S,7S,9R,11S,12S,16S)-15-acetyl-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-14-en-5-yl] acetate C23H32O4
2,4-dihydroxy-6-methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid C23H32O4
(6aR,9S)-9-ethoxy-6,6,9-trimethyl-3-pentyl-7,8-dihydro-6aH-benzo[c]chromene-1,4-dione C23H32O4
1-[(8S,13S,14S,17R)-17-hydroxy-13-methylspiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-yl]propan-1-one C23H32O4